BARCELONA — Indonesia’s contribution to global dermatology took center stage as a leading dermatology expert from Universitas Diponegoro (Undip), Dr. dr. Renni Yuniati, SpDVE, Subsp DT, FINSDV, FAADV, MH, delivered a keynote address at the International Congress of Dermatology and Cosmetology, held in Barcelona, Spain, from 22–24 June 2026.
In her scientific presentation, titled “Latest Innovations in Leprosy Diagnosis and Therapy: Towards Accelerating Global Elimination,” Dr. Renni highlighted that leprosy remains a significant global public health challenge. More than 170,000 new cases are reported worldwide each year, with nearly 10,000 occurring among children.
“Leprosy is not only a disease with a thousand faces but also one deeply intertwined with social discrimination and stigma. The detection of cases among children is a warning that transmission remains active. The medical innovations we discuss today must reach even the most remote communities if we are to accelerate global elimination,” Dr. Renni said during her presentation.

In front of global leaders in dermatology and infectious diseases, Dr. Renni presented a series of cutting-edge innovations that have the potential to reshape the global fight against leprosy. On the diagnostic front, she highlighted the CRADAR-i portable molecular testing device, which can deliver same-day results without requiring electricity, rapid lateral flow assays, and the application of artificial intelligence (AI), which now achieves diagnostic accuracy of more than 90 percent.
On the therapeutic side, she introduced two promising breakthrough drugs Bedaquiline and Telacebec—which offer the potential for ultra-short treatment regimens, with the possibility of a single-dose therapy.
“Innovations such as ultra-short therapy and the LepVax vaccine are not merely technological advances; they represent new hope for patients to regain normal lives without fear of disability. We must ensure that these treatments are made available equitably and free of charge to those who need them,” she added.
Representing Indonesia, the country with the world’s third-highest burden of leprosy, Dr. Renni emphasized the nation’s and Universitas Diponegoro’s role at the forefront of research and implementation in the fight against the disease.
“Achieving a leprosy-free world is no longer a distant dream—it is a reality that our generation can accomplish. Let us work together to eliminate the stigma surrounding leprosy and restore hope and dignity to survivors so they can fully recover,” Dr. Renni concluded, receiving enthusiastic applause from the audience.
Dr. Renni’s appearance marked a proud moment for Indonesia, highlighting the country’s growing contribution to the global medical community and showcasing Universitas Diponegoro’s research excellence on the international stage. (Public Relations, Faculty of Medicine Undip)




